Variability of morphine disposition during long-term subcutaneous infusion in terminally ill cancer patients

European Journal of Clinical Pharmacology

Volumn 53, Issue 5, 1998, Pages 325-330

  Vermeire, A ^a   Remon, J P ^a   Rosseel, M T ^b   Belpaire, F ^b   Devulder, J ^c   Bogaert, M G ^b  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Cancer patients; Morphine disposition; Subcartaneous infusion

Indexed keywords

GLUCURONIDE; MORPHINE;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER; CANCER PAIN; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG DISPOSITION; DRUG INFUSION; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIQUID CHROMATOGRAPHY; MALE; MEASUREMENT; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TERMINALLY ILL PATIENT;

AGED; ANALGESICS, OPIOID; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; MORPHINE; NEOPLASMS; TERMINAL CARE; TERMINALLY ILL;

EID: 0031952046     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050387     Document Type: Article

References (12)

1. Hoskin PJ, Hanks GW (1990) Morphine: pharmacokinetics and clinical practice. Br J Cancer 62: 705-707
2. Milne RW, Nation RL, Reynolds GD, Somogyi AA, Van Crugten JT (1991) High-performance liquid chromatographic determination of morphine and its 3- and 6-glucuronide metabolites: improvements to the method and application to stability studies. J Chromatogr Biomed Appl 565: 457-464
3. Rotshteyn Y, Weingarten B (1996) A highly sensitive assay for the simultaneous determination of morphine, morphine-3-glucuronide, and morphine-6-glucuronide in human plasma by high-performance liquid chromatography with electrochemical and fluorescence detection. Ther Drug Monit 18: 179-188
4. Vermeire A, Remon JP (1997) The solubility of morphine and the stability of concentrated morphine solutions in glass, polypropylene syringes and PVC containers. Int J Pharm 146: 213-223
5. Glare PA, Walsh TD, Pippenger CE (1991) A simple, rapid method for the simultaneous determination of morphine and its principal metabolites in plasma using high-performance liquid chromatography and fluorometric detection. Ther Drug Monit 13: 226-232
6. Nahata MC, Miser AW, Miser JS, Reuning RH (1984) Analgesic plasma concentrations of morphine in children with terminal malignancy receiving a continuous subcutaneous infusion of morphine sulfate to control severe pain. Pain 18: 109-114
7. Peterson GM, Randall CTC, Paterson J (1990) Plasma levels of morphine and morphine glucuronides in the treatment of cancer pain: relationship to renal function and route of administration. Eur J Clin Pharmacol 38: 121-124
8. Hung CT, Young M, Gupta PK (1988) Stability of morphine solutions in plastic syringes determined by reversed-phase ion-pair liquid chromatography. J Pharm Sci 77: 719-723
9. Säwe J, Svensson JO, Rane A (1983) Morphine metabolism in cancer patients on increasing oral doses no evidence for autoinduction or dose-dependence. Br J Clin Pharmacol 16: 85 93
10. Olsen GD (1974) Morphine binding to human plasma proteins. Clin Pharmacol Ther 17: 31-35
11. Glare PA, Walsh TD (1991) Clinical pharmacokinetics of morphine. Ther Drug Monit 13: 1-23
12. Lemmer B, Nold G (1991) Circadian changes in estimated hepatic blood flow in healthy subjects. Br J Clin Pharmacol 32: 627-629